314 related articles for article (PubMed ID: 18586314)
1. Smoking increases the risk of high-grade vaginal intraepithelial neoplasia in women with oncogenic human papillomavirus.
Sherman JF; Mount SL; Evans MF; Skelly J; Simmons-Arnold L; Eltabbakh GH
Gynecol Oncol; 2008 Sep; 110(3):396-401. PubMed ID: 18586314
[TBL] [Abstract][Full Text] [Related]
2. The distribution of low and high-risk HPV types in vulvar and vaginal intraepithelial neoplasia (VIN and VaIN).
Srodon M; Stoler MH; Baber GB; Kurman RJ
Am J Surg Pathol; 2006 Dec; 30(12):1513-8. PubMed ID: 17122506
[TBL] [Abstract][Full Text] [Related]
3. Prediction of persistent vaginal intraepithelial neoplasia in previously hysterectomized women by high-risk HPV DNA detection.
Frega A; French D; Piazze J; Cerekja A; Vetrano G; Moscarini M
Cancer Lett; 2007 May; 249(2):235-41. PubMed ID: 17070990
[TBL] [Abstract][Full Text] [Related]
4. Low-grade vulvar and vaginal intraepithelial neoplasia: correlation of histologic features with human papillomavirus DNA detection and MIB-1 immunostaining.
Logani S; Lu D; Quint WG; Ellenson LH; Pirog EC
Mod Pathol; 2003 Aug; 16(8):735-41. PubMed ID: 12920216
[TBL] [Abstract][Full Text] [Related]
5. [Vaginal intraepithelial neoplasia and human papillomavirus infection: a report of 75 cases].
Indraccolo U; Del Frate E; Cenci S; Ubertosi M; Donati Sarti R; Donati Sarti C; Baldoni A
Minerva Ginecol; 2006 Apr; 58(2):101-8. PubMed ID: 16582866
[TBL] [Abstract][Full Text] [Related]
6. The prevalence of human papillomavirus genotypes in nonmelanoma skin cancers of nonimmunosuppressed individuals identifies high-risk genital types as possible risk factors.
Iftner A; Klug SJ; Garbe C; Blum A; Stancu A; Wilczynski SP; Iftner T
Cancer Res; 2003 Nov; 63(21):7515-9. PubMed ID: 14612553
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and type distribution of high-risk human papillomavirus infection in women undergoing voluntary cervical cancer screening in Italy.
Agarossi A; Ferrazzi E; Parazzini F; Perno CF; Ghisoni L
J Med Virol; 2009 Mar; 81(3):529-35. PubMed ID: 19152401
[TBL] [Abstract][Full Text] [Related]
8. Analytical evaluation of the PapilloCheck test, a new commercial DNA chip for detection and genotyping of human papillomavirus.
Dalstein V; Merlin S; Bali C; Saunier M; Dachez R; Ronsin C
J Virol Methods; 2009 Mar; 156(1-2):77-83. PubMed ID: 19041893
[TBL] [Abstract][Full Text] [Related]
9. A pilot study on the distribution of human papillomavirus genotypes and HPV-16 variants in cervical neoplastic lesions from Ecuadorian women.
Tornesello ML; Buonaguro L; Izzo S; Lopez G; Vega X; Maldonado Reyes CF; Buonaguro FM
J Med Virol; 2008 Nov; 80(11):1959-65. PubMed ID: 18814248
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of the most common high-risk HPV genotypes among women in three new independent states of the former Soviet Union.
Kulmala SM; Shabalova IP; Petrovitchev N; Syrjänen KJ; Gyllensten UB; Syrjänen SM;
J Med Virol; 2007 Jun; 79(6):771-81. PubMed ID: 17457909
[TBL] [Abstract][Full Text] [Related]
11. Vaccinia-expressed human papillomavirus 16 and 18 e6 and e7 as a therapeutic vaccination for vulval and vaginal intraepithelial neoplasia.
Baldwin PJ; van der Burg SH; Boswell CM; Offringa R; Hickling JK; Dobson J; Roberts JS; Latimer JA; Moseley RP; Coleman N; Stanley MA; Sterling JC
Clin Cancer Res; 2003 Nov; 9(14):5205-13. PubMed ID: 14614000
[TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus in vaginal intraepithelial neoplasia.
Chao A; Chen TC; Hsueh C; Huang CC; Yang JE; Hsueh S; Huang HJ; Lin CT; Tang YH; Liou JD; Chang CJ; Chou HH; Lai CH
Int J Cancer; 2012 Aug; 131(3):E259-68. PubMed ID: 22095387
[TBL] [Abstract][Full Text] [Related]
13. Characterization of human papillomavirus infection in north Taiwan.
Wang CH; Garvilles RG; Chen CY
J Med Virol; 2010 Aug; 82(8):1416-23. PubMed ID: 20572075
[TBL] [Abstract][Full Text] [Related]
14. High prevalence of high-risk oncogenic human papillomaviruses harboring atypical distribution in women of childbearing age living in Libreville, Gabon.
Si-Mohamed A; Ndjoyi-Mbiguino A; Cuschieri K; Onas IN; Colombet I; Ozouaki F; Goff JL; Cubie H; Bélec L
J Med Virol; 2005 Nov; 77(3):430-8. PubMed ID: 16173023
[TBL] [Abstract][Full Text] [Related]
15. A population-based study of squamous cell vaginal cancer: HPV and cofactors.
Daling JR; Madeleine MM; Schwartz SM; Shera KA; Carter JJ; McKnight B; Porter PL; Galloway DA; McDougall JK; Tamimi H
Gynecol Oncol; 2002 Feb; 84(2):263-70. PubMed ID: 11812085
[TBL] [Abstract][Full Text] [Related]
16. HPV genotype prevalence in women with abnormal pap smears in Melbourne, Australia.
Stevens MP; Garland SM; Tan JH; Quinn MA; Petersen RW; Tabrizi SN
J Med Virol; 2009 Jul; 81(7):1283-91. PubMed ID: 19475612
[TBL] [Abstract][Full Text] [Related]
17. Retrospective study of the prevalence of high-risk human papillomaviruses among Croatian women.
Milutin-Gasperov N; Sabol I; Halec G; Matovina M; Grce M
Coll Antropol; 2007 Apr; 31 Suppl 2():89-96. PubMed ID: 17598510
[TBL] [Abstract][Full Text] [Related]
18. Effect of human papillomavirus vaccines on vulvar, vaginal, and anal intraepithelial lesions and vulvar cancer.
Hampl M; Sarajuuri H; Wentzensen N; Bender HG; Kueppers V
Obstet Gynecol; 2006 Dec; 108(6):1361-8. PubMed ID: 17138767
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of HPV genotypes determined by PCR and DNA sequencing in cervical specimens from French women with or without abnormalities.
Pannier-Stockman C; Segard C; Bennamar S; Gondry J; Boulanger JC; Sevestre H; Castelain S; Duverlie G
J Clin Virol; 2008 Aug; 42(4):353-60. PubMed ID: 18485810
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and genotype distribution of multiple human papillomavirus infection in the uterine cervix: a 7.5-year longitudinal study in a routine cytology-based screening population in West Germany.
Kovács K; Varnai AD; Bollmann M; Bankfalvi A; Szendy M; Speich N; Schmitt C; Pajor L; Bollmann R
J Med Virol; 2008 Oct; 80(10):1814-23. PubMed ID: 18712836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]